The 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East kicked off yesterday. The conference is being hosted by Khalifa University in Abu Dhabi from April 18 to 20.
This prominent scientific event brings together a select group of global leaders, researchers, healthcare professionals, and patient advocates to advance a shared understanding of Alzheimer’s disease and develop innovative strategies for diagnosis, treatment, and care in the region.
Professor Marwan Sabbagh, Fellow of the American Academy of Neurology and Chair of the Alzheimer’s Disease Research Division at Arizona State University, USA, told Emirates News Agency (WAM) that this conference aims to foster dialogue among leaders, physicians, and scientists to develop new treatments for Alzheimer’s disease, a necessary development in addressing the challenges posed by the disease at the regional and global levels.
He added that in its early days, the conference focused on facilitating discussions among specialists. Today, it has evolved to include a deeper understanding of regional issues, ways to integrate modern technology, and the development of new tests and treatments applicable to the Middle East, thus contributing to the spread of benefits to all countries.
He emphasized that the primary goal of the conference is to enhance global scientific and medical cooperation to find effective and innovative solutions to address Alzheimer’s and related disorders, noting that the conference plays a pivotal role in shaping the future of Alzheimer’s care in our region. By unifying efforts across disciplines and borders, we are making real progress towards improving patient outcomes and enhancing the quality of life for their families.
The conference is sponsored by a number of major healthcare entities in the UAE and aims to address the growing challenges associated with dementia disorders through the exchange of expertise and the promotion of cooperation and innovation.
The three-day program includes opening remarks by international experts, specialized keynote sessions, and extensive discussions within working groups.
The sessions focus on the latest scientific developments in the fields of early diagnosis, pharmacological and non-pharmacological treatments, integrated care models, regulatory frameworks, and related health policies.
The conference addresses the social and economic impact of dementia disorders, explores early awareness programs, and community and cultural support for caregivers, while focusing on sustainable solutions that enhance the ability of health systems to respond to growing challenges.
This conference is a prestigious international platform that brings together researchers, physicians, experts, and policymakers to discuss the latest developments in Alzheimer’s research and propose practical and innovative solutions aimed at improving the quality of life for those affected and supporting their families and caregivers. It also ÐÇ¿Õ´«Ã½ advances in diagnosis and treatment, showcases innovations in healthcare technologies and community services, and discusses national and international policies related to neurological diseases.
The conference represents a significant step forward in the UAE’s efforts to strengthen its position as a global platform for medical innovation and scientific research, and to support international efforts to address the challenges of dementia and associated neurological disorders.
Source: Ìý
